Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
(DCPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Qinlock
Ripretinib
2020-05-15
2030-2042
Gastrointestinal stromal tumors
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ripretinib
systemic mastocytosis
,
mastocytosis
,
neoplasms
,
gastrointestinal stromal tumors
Cilmostim
neoplasms
,
synovitis
,
giant cell tumors
,
pigmented villonodular synovitis
,
giant cell tumor of tendon sheath
Alfacalcidol
neoplasms
,
gastrointestinal stromal tumors
,
systemic mastocytosis
,
mastocytosis
Bevifimod
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
castration-resistant prostatic neoplasms
,
pancreatic ductal carcinoma
,
mutation rate
,
gastrointestinal stromal tumors
REBASTINIB
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
carcinoma
,
breast neoplasms
,
adenocarcinoma
,
neoplasms
Gluconorm
gastrointestinal stromal tumors
Hsct
graft vs host disease
,
bronchiolitis obliterans syndrome
Sti571
gastrointestinal stromal tumors
Arm1
gastrointestinal stromal tumors
Arm2
gastrointestinal stromal tumors
E7389
carcinoma
,
breast neoplasms
,
adenocarcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use